Drug
fedratinib hydrochloride
Marketed as INREBIC.
Generic name
fedratinib hydrochloride
Brand names
INREBIC
First FDA approval
2019-08-16
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA212327 | INREBIC | 2019-08-16 | BRISTOL-MYERS |
Manufacturers
BRISTOL-MYERS
Frequently asked questions
When was fedratinib hydrochloride FDA approved?
Earliest FDA approval on record: 2019-08-16.
What brand names are sold as fedratinib hydrochloride?
INREBIC.
Sources
Appeal a fedratinib hydrochloride denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com